Fingerprint
Dive into the research topics of 'Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Patricia M. LoRusso, Alex A. Adjei, Mary Varterasian, Shirish Gadgeel, Joel Reid, David Y. Mitchell, Lorelei Hanson, Pamela DeLuca, Laura Bruzek, Jill Piens, Peggy Asbury, Keri Van Becelaere, Roman Herrera, Judith Sebolt-Leopold, Mark B. Meyer
Research output: Contribution to journal › Article › peer-review